Literature DB >> 15623709

Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

M P J Garssen1, J B J Bussmann, P I M Schmitz, A Zandbergen, T G Welter, I S J Merkies, H J Stam, P A van Doorn.   

Abstract

Many patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) experience excessive fatigue, which may persist for years and reduce quality of life. The authors performed a 12-week study of bicycle exercise training in 20 patients with severe fatigue, 16 with relatively good recovery from GBS, and 4 with stable CIDP. Training seemed well tolerated, and self-reported fatigue scores decreased 20% (p = 0.001). Physical fitness, functional outcome, and quality of life were improved.

Entities:  

Mesh：

Year:  2004        PMID： 15623709     DOI： 10.1212/01.wnl.0000148589.87107.9c

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  29 in total

1.  Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome.

Authors:  F Khan; J F Pallant; L Ng; A Bhasker
Journal:  J Neurol       Date:  2010-07-13       Impact factor: 4.849

Review 2.  Neuropsychological/-psychiatric deficits in immune-mediated neuropathies.

Authors:  Andrew Chan; Ralf Gold
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

3.  Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Ivo Bozovic; Aleksandra Kacar; Stojan Peric; Ana Nikolic; Bogdan Bjelica; Mina Cobeljic; Milutin Petrovic; Aleksandar Stojanov; Vanja Djuric; Miroslav Stojanovic; Gordana Djordjevic; Vesna Martic; Aleksandra Dominovic; Zoran Vukojevic; Ivana Basta
Journal:  J Neurol       Date:  2017-10-30       Impact factor: 4.849

4.  Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trial.

Authors:  M P J Garssen; P I M Schmitz; I S J Merkies; B C Jacobs; F G A van der Meché; P A van Doorn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

Review 5.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 6.  Immune-mediated neuropathies.

Authors:  Bernd C Kieseier; Emily K Mathey; Claudia Sommer; Hans-Peter Hartung
Journal:  Nat Rev Dis Primers       Date:  2018-10-11       Impact factor: 52.329

7.  Fatigue: an important feature of late-onset Pompe disease.

Authors:  Marloes L C Hagemans; Sabine P M van Schie; A Cecile J W Janssens; Pieter A van Doorn; Arnold J J Reuser; Ans T van der Ploeg
Journal:  J Neurol       Date:  2007-03-02       Impact factor: 4.849

8.  Fatigue is part of the burden of neuromuscular diseases.

Authors:  John H J Wokke
Journal:  J Neurol       Date:  2007-02-26       Impact factor: 4.849

Review 9.  Fatigue in neuromuscular disorders: focus on Guillain-Barré syndrome and Pompe disease.

Authors:  J M de Vries; M L C Hagemans; J B J Bussmann; A T van der Ploeg; P A van Doorn
Journal:  Cell Mol Life Sci       Date:  2010-03       Impact factor: 9.261

10.  Functioning of patients with chronic idiopathic axonal polyneuropathy (CIAP).

Authors:  Peter G Erdmann; Laurien L Teunissen; Frank R van Genderen; Nicolette C Notermans; Eline Lindeman; Paul J M Helders; Nico L U van Meeteren
Journal:  J Neurol       Date:  2007-03-25       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.